![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 317/54 | |
A61K 31/343 | |||
A61P 13/04 | |||
A61P 13/12 |
(11) | Number of the document | 3416955 |
(13) | Kind of document | T |
(96) | European patent application number | 17704274.4 |
Date of filing the European patent application | 2017-02-14 | |
(97) | Date of publication of the European application | 2018-12-26 |
(45) | Date of publication and mention of the grant of the patent | 2020-09-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2017/053245 |
Date | 2017-02-14 |
(87) | Number | WO 2017/140658 |
Date | 2017-08-24 |
(30) | Number | Date | Country code |
16305173 | 2016-02-15 | EP | |
16305698 | 2016-06-10 | EP |
(72) |
LETAVERNIER, Emmanuel, FR
DAUDON, Michel, FR
|
(73) |
Institut National de la Santé et de la Recherche Médicale (INSERM),
101, rue de Tolbiac, 75013 Paris,
FR
Assistance Publique - Hōpitaux de Paris, 3 avenue Victoria, 75004 Paris, FR Sorbonne Université, 21 Rue de l`Ecole de Médecine, 75006 Paris, FR |
(54) | USE OF STIRIPENTOL AND THEIR DERIVATIVES FOR DECREASING URINARY OXALATE CONCENTRATION IN AN INDIVIDUAL |
USE OF STIRIPENTOL AND THEIR DERIVATIVES FOR DECREASING URINARY OXALATE CONCENTRATION IN AN INDIVIDUAL |